GlassScriptPhysician profile
Tyler P Mancil
NPI 1154871275
$6,843.61
in general payments reported to CMS, 2019-2025
12 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $159 · 2021: $4,706 · 2022: $508 · 2023: $655 · 2024: $422 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,363.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,465.00 | 2021 | |
| Organogenesis INC. | $1,412.41 | 2019-2025 | Puraply, Affinity, Cygnus Dual |
| Paratek Pharmaceuticals, INC. | $641.19 | 2020-2023 | Nuzyra |
| Stryker Corporation | $440.85 | 2019-2024 | Asnis, Ortholoc 2 Lapifuse |
| Smith+Nephew, INC. | $314.84 | 2019-2023 | Grafix Pl, Stravix Pl, Stravix |
| Depuy Synthes Sales INC. | $219.93 | 2019-2025 | Motoband, Hammerlock |
| Hartmann USA, INC. | $117.66 | 2021-2023 | Zetuvit Plus |
| Kerecis Limited | $76.99 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kci USA, INC. | $58.63 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $45.38 | 2024-2025 | Activbraid, Tapestry |
| Treace Medical Concepts, INC. | $36.48 | 2025 | |
| Abbvie INC. | $14.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Mancil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.